Understanding Providers' Readiness and Attitudes Toward Autoantibody Screening: A Mixed-Methods Study

Area of Science:

• Endocrinology and immunology research.
• Clinical trial and screening program evaluation.
• Public health and preventative medicine.

Background:

• Type 1 diabetes (T1D) screening for autoantibodies aids in identifying individuals at high risk of disease progression.
• Limited T1D prevention strategies and lack of a cure present challenges for screening programs.
• Emerging treatments like teplizumab for delaying T1D onset necessitate re-evaluating screening protocols.

Purpose of the Study:

• To assess endocrinologists' awareness and readiness for T1D autoantibody screening.
• To understand endocrinologists' attitudes towards implementing T1D autoantibody screening programs.
• To explore factors influencing the adoption of T1D screening among endocrine providers.

Main Methods:

• Survey distributed to endocrinology providers.
• Data collection on awareness, readiness, and attitudes regarding T1D autoantibody screening.
• Analysis of provider perspectives on screening barriers and facilitators.

Main Results:

• Findings on the current level of awareness and readiness among endocrinologists.
• Insights into provider attitudes, including perceived benefits and challenges of screening.
• Identification of key factors influencing the potential implementation of T1D screening.

Conclusions:

• Endocrinologists' perspectives are crucial for successful T1D screening program implementation.
• Understanding provider attitudes can inform strategies to overcome barriers to screening.
• Readiness for screening may be influenced by awareness of new therapeutic options like teplizumab.